Invention Application
- Patent Title: CML THERAPEUTIC AGENTS WITH REDUCED DRUG-RESISTANCE AND SIDE-EFFECT COMPRISING 1,6-DISUBSTITUTED INDOLE COMPOUNDS
-
Application No.: US15677742Application Date: 2017-08-15
-
Publication No.: US20180050036A1Publication Date: 2018-02-22
- Inventor: Tae Bo SIM , Ho Jong YOON , Woo Young HUR , Yun Ju NAM , Hwan Geun CHOI
- Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Applicant Address: KR Seoul
- Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee Address: KR Seoul
- Priority: KR10-2016-0103814 20160816
- Main IPC: A61K31/506
- IPC: A61K31/506
Abstract:
The present invention relates to a therapeutic agent for chronic myelogenous leukemia with reduced drug-resistance and side-effects containing a 1,6-disubstituted indole compound.
Public/Granted literature
Information query
IPC分类:
